Notícias

Strong sales of blood thinner Eliquis and newer drugs Camzyos and Reblozyl pushed second-quarter revenue to $12.97 billion, above analyst estimates

PSX heads into Q2 earnings with stronger estimates, softer crude costs and refinery strength, though its premium valuation raises the stakes.

Carvana stock declines with Wall Street unwilling to ‘reward’ the used-car retailer’s full-year earnings guidance.

The luxury sports-car maker lifted full-year guidance slightly and reported a ramped up deliveries of new models in the second quarter.

The chipmaker plans to raise prices starting September 1 to offset industry-wide cost increases, while its outlook for the current quarter came in below analyst expectations

PBF Energy (PBF) delivered earnings and revenue surprises of +53.58% and +37.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

KKR & Co. (KKR) delivered earnings and revenue surprises of +14.79% and +13.47%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Canada Goose (GOOS) delivered earnings and revenue surprises of -1.59% and +6.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Solstice, a cooling technology supplier, reported adjusted EPS of 88 cents. Wall Street was looking for 77 cents.

Teladoc Health (NYSE:TDOC) reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at BetterHelp prompted the company to reduce its full-year revenue outlook. Consolidated

AEM beat Q2 earnings estimates as higher gold prices lifted profit, while updated production and spending guidance points to key shifts ahead.

Wall Street keeps reaching for the dot-com playbook every time an AI stock surges, but Fox Business host Charles Payne thinks that reflex is costing investors something far more valuable than peace of mind.

Barclays lowered its Robinhood price target to $105 from $122 and cited a meaningful slowdown in new accounts during July.

The South Korean tech giant's memory chip division hit all-time highs on AI server demand, while elevated component costs pushed its mobile unit into the red

Norwegian Cruise Line (NCLH) delivered earnings and revenue surprises of +23.08% and +0.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ares Capital continues to provide investors with a durable stream of dividend income.

European bourses tracked moderately higher midday Thursday as traders weighed the earnings season, s

Valero Energy (VLO) delivered earnings and revenue surprises of +27.05% and +23.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Check Point (CHKP) delivered earnings and revenue surprises of +4.08% and -0.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Investing.com -- Ferrari N.V. (NYSE: RACE) reported second-quarter results that fell short of analyst expectations but raised its full-year guidance, sending shares up 5% premarket as investors focused on stronger-than-expected personalization demand.

Trane Technologies (TT) delivered earnings and revenue surprises of +0.94% and +2.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Coinbase reports Q2 earnings after the close on July 30, with Wall Street expecting a soft quarter. Consensus revenue sits near $1.31 billion, down roughly 13% year over year. The EPS consensus has slipped to about $0.15, while HC Wainwright projects $0.05. The bigger question is whether management can justify ...

Xcel (XEL) delivered earnings and revenue surprises of +17.72% and -13.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The coffee chain posted its fourth straight quarter of comparable sales growth and now expects adjusted EPS of $2.55 to $2.65 for fiscal 2026

Bristol Myers Squibb faces declining revenue in its legacy drug portfolio, but new products like Opdivo are offsetting the drop.

Qorvo shares have fallen 54.0% over the past five years, yet current checks suggest the stock now sits close to its estimated intrinsic value, with market multiples hinting at some undervaluation. That mix leaves Qorvo looking neither like an obvious bargain nor clearly overpriced at the recent US$89.50 close. The 54.0% share price decline over five years means long term holders have absorbed a sizeable drawdown that frames how cautious many investors may feel today. Future cash flow...

The software company beat Wall Street expectations on revenue and earnings as Azure growth accelerated to 43% in the fourth quarter

Wall Street futures pointed higher pre-bell Thursday after tech colossus Microsoft (MSFT) reported s

Cigna (CI) delivered earnings and revenue surprises of +2.64% and +0.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Norfolk Southern (NSC) has drawn fresh attention after reporting second quarter 2026 results that showed net income of US$734 million and earnings per share of US$3.26 from continuing operations, compared with the prior year period. See our latest analysis for Norfolk Southern. Norfolk Southern shares have climbed, with a year to date share price return of 16.65% and a 1 year total shareholder return of 22.57%. This suggests that momentum has been supported by recent earnings, dividend...